Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains

A neuropathic pain and formylphenyl technology, which is applied in the field of use of 4-formylphenyl-β-D-glycosides for the treatment of chronic neuropathic pain, and can solve the problem of being unsuitable for screening neuralgia treatment drugs, etc. question

Inactive Publication Date: 2010-09-15
YUNNAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hot plate, tail flick, and writhing are classic animal models commonly used to screen acute pain analgesics, but they are not suitable for screening neuralgia drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains
  • Application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains
  • Application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of 4-formylphenyl-beta-D-glucoside compounds in treating chronic neuropathic pains, which uses a compound of the formula (disclosed in the specification) as a ligand, wherein a glycosyl part is arbitrary pyranose or furanose; the 4-formylphenyl-beta-D-glucoside compounds comprise a pharmaceutically acceptable salt, ester and a solvate, and the application relates to the application the salt, the ester and the solvate in preparing medicaments for treating the neuropathic pains; a representative compound is 4-formylphenyl-beta-D-xyloside; and the structural formula is disclosed in the specification. On a classical sciatic nerve chronic compression injury (CCI) model, through single intragastric administration and continuous intragastric administration for 7 days, the compound shows definite treatment effect on resisting nervous pains. At a dose point appointed by an experiment, the compound can obviously improve the mechanical stimulus pain threshold, the nervous pain resistant efficacy is equivalent to that of Gabapentin which is a contrast medicament, and the duration is superior to that of the Gabapentin. Proved by research results, the compound can be used for treating the chronic neuropathic pains.

Description

technical field The present invention relates to pharmaceutical compounds in the fields of medicine, health and chemistry, in particular to the use of 4-formylphenyl-β-D-glucoside compounds and pharmaceutically acceptable salts, esters and solvates thereof for the treatment of chronic neurogenic pain . Background technique According to the duration of pain, pain is clinically classified into two types: acute pain and chronic pain. These two types of pain have essential differences in the mechanism of occurrence. Acute pain is called nociceptive pain, that is, pain caused by tissue trauma. With the repair of tissue trauma, the pain stops naturally. Analgesics, such as narcotic analgesics and non-steroidal antipyretic analgesics, can be used during the onset Chronic pain is mainly neurogenic pain, its pathogenesis is complex, and it is difficult to cure it. It is a new field of basic and clinical research and drug development of pain medicine. It has risen abroad for about 3...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7034A61P25/00A61P25/04A61P29/00A61K31/195
Inventor 戴晓畅肖涵
Owner YUNNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products